Sanofi (SNY) Free Cash Flow (2009 - 2026)

Sanofi has disclosed Free Cash Flow across 10 years of filings, most recently posting $3.4 billion for Q2 2026.

• In Q2 2026, Free Cash Flow rose 107.9% year-over-year to $3.4 billion; the TTM figure through Jun 2026 stood at $21.3 billion (up 35.84% YoY), while the FY2025 annual figure was $8.4 billion, up 31.78% from the prior year.
• Free Cash Flow came in at $3.4 billion for Q2 2026 at Sanofi, up from $2.0 billion in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $11.2 billion in Q4 2022 to a low of $95.6 million in Q1 2024.
• Average Free Cash Flow over 5 years is $4.0 billion, with a median of $3.2 billion recorded in 2022.
• Year-over-year, Free Cash Flow sank 96.76% in 2024 and soared 2202.93% in 2025.
• Over 5 years, Free Cash Flow stood at $11.2 billion in 2022, then plunged by 56.76% to $4.9 billion in 2023, then fell by 23.31% to $3.7 billion in 2024, then surged by 96.8% to $7.3 billion in 2025, then sank by 53.12% to $3.4 billion in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $3.4 billion in Q2 2026, $2.0 billion in Q1 2026, and $7.3 billion in Q4 2025.